Parallax Volatility Advisers
BRLI

Parallax Volatility Advisers’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Parallax Volatility Advisers’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-63
Closed -$1.65K – 3893
2013
Q4 		$2K Sell
63
-717
-92% -$22.1K ﹤0.01% 3264
2013
Q3 		$23K Buy
780
+114
+17% +$3.17K ﹤0.01% 2209
2013
Q2 		$19K Buy
+666
New +$18.4K ﹤0.01% 2023

Other funds holding BRLI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Parallax Volatility Advisers's BRLI Position: Q1 2014 in Review

Parallax Volatility Advisers sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q1 2014, closing a stake of 63 shares — an estimated $1.65K sold.

Parallax Volatility Advisers first reported a position in BRLI in Q2 2013 and held it in 3 quarters. The position peaked at $23K in Q3 2013. 162 funds tracked by Wall St. Rank hold BRLI as of Q1 2014.

  • Parallax Volatility Advisers reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q1 2014 after selling out during the quarter.
  • Parallax Volatility Advisers sold 63 BIO-REFERENCE LABS INC-NEW- shares in Q1 2014, an estimated $1.65K.
  • Parallax Volatility Advisers first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 3 quarters.
  • Parallax Volatility Advisers's BIO-REFERENCE LABS INC-NEW- position peaked at $23K in Q3 2013.
  • 162 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q1 2014.

Based on Parallax Volatility Advisers's 13F filing for Q1 2014, filed 15 May 2014.